This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical...

Cross-border and domestic merger and acquisitions are considered as fastest means of growth and survival too. This study provides evidence on the value creation by applying inorganic growth strategies based on a sample of Indian pharmaceutical companies. Relying on the key financial ratios,...

Multinational companies (MNCs) from emerging markets (EMs) are new and very dynamic actors on the global scene. Starting from the late 1970s a strand of literature flourished on Third World multinationals (Lall, 1983a). More recently, the increasing expansion abroad by multinationals based in...